BioStock: CLS makes progress in prostate cancer in Europe and the US
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

BioStock: CLS makes progress in prostate cancer in Europe and the US

Clinical Laserthermia Systems has treated its first prostate cancer patients in Italy and secured additional orders and agreements in the US. In addition, the company has presented initial clinical data from the study at Radboud University Medical Center in the Netherlands.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/04/cls-makes-progress-in-prostate-cancer-in-europe-and-the-us/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Nyheter om Clinical Laserthermia

Läses av andra just nu

Om aktien Clinical Laserthermia

Senaste nytt